全文获取类型
收费全文 | 315篇 |
免费 | 21篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 7篇 |
妇产科学 | 13篇 |
基础医学 | 32篇 |
口腔科学 | 11篇 |
临床医学 | 18篇 |
内科学 | 93篇 |
神经病学 | 9篇 |
特种医学 | 12篇 |
外科学 | 28篇 |
预防医学 | 15篇 |
眼科学 | 3篇 |
药学 | 14篇 |
中国医学 | 1篇 |
肿瘤学 | 80篇 |
出版年
2023年 | 2篇 |
2022年 | 7篇 |
2021年 | 12篇 |
2020年 | 11篇 |
2019年 | 10篇 |
2018年 | 20篇 |
2017年 | 11篇 |
2016年 | 3篇 |
2015年 | 9篇 |
2014年 | 10篇 |
2013年 | 17篇 |
2012年 | 23篇 |
2011年 | 36篇 |
2010年 | 14篇 |
2009年 | 17篇 |
2008年 | 16篇 |
2007年 | 22篇 |
2006年 | 14篇 |
2005年 | 10篇 |
2004年 | 17篇 |
2003年 | 14篇 |
2002年 | 14篇 |
2001年 | 6篇 |
2000年 | 1篇 |
1999年 | 3篇 |
1998年 | 4篇 |
1997年 | 1篇 |
1996年 | 2篇 |
1995年 | 1篇 |
1993年 | 2篇 |
1990年 | 1篇 |
1987年 | 1篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1981年 | 2篇 |
1978年 | 1篇 |
1973年 | 1篇 |
1968年 | 1篇 |
排序方式: 共有338条查询结果,搜索用时 15 毫秒
21.
22.
Update in infectious diseases in liver transplant recipients 总被引:2,自引:0,他引:2
Huprikar S 《Clinics in Liver Disease》2007,11(2):337-354
The prevention and management of bacterial, fungal, and viral infections are important components in the care of the liver transplant recipient. Although much progress has been made, challenges still remain. This article provides updates on the management of bilomas and peritonitis, the prevention and management of invasive Candida and Aspergillus infections, the prevention and management of cytomegalovirus disease, and the current status of liver transplantation in HIV-infected patients. 相似文献
23.
Bryan J. Schneider Francis P. Worden Shirish M. Gadgeel Ralph E. Parchment Collette M. Hodges James Zwiebel Rodney L. Dunn Antoinette J. Wozniak Michael J. Kraut Gregory P. Kalemkerian 《Investigational new drugs》2009,27(6):571-578
Background Alterations in retinoid signaling appear to be involved in the pathogenesis of small cell lung cancer (SCLC). Fenretinide
[N-(4-hydroxyphenyl)retinamide], a synthetic retinoid, inhibits the growth of SCLC cells in vitro via the induction of apoptosis. Since these data suggested that SCLC is the adult solid tumor that is most susceptible to
fenretinide, a trial to evaluate the clinical activity of fenretinide in patients with SCLC was considered the definitive
test of its clinical potential in adult oncology. Methods Patients with progressive SCLC after one or two prior chemotherapy regimens and a performance status of 0–2 were eligible
for the study. Patients with stable, treated brain metastases were eligible. Fenretinide 900 mg/m2 twice daily was administered orally on days 1–7 of each 21-day cycle. Blood and saliva were collected pre-treatment and on
day 7 of cycle 1 to measure fenretinide and retinol levels by high-pressure liquid chromatography (HPLC). Results Nineteen patients were enrolled. Fifteen patients had one prior chemotherapy regimen and four patients had two prior regimens.
The median time from diagnosis to enrollment was 10 months. A median of two cycles of fenretinide was administered. There
were no objective responses, but four of 17 evaluable patients (24%) had stable disease after 2–17 cycles. The median time
to treatment failure was 5.7 weeks overall, while the four patients with stable disease demonstrated treatment failure at
11, 13, 19, and 52 weeks. Median survival was 25 weeks, with one patient alive 22 months after the start of treatment. The
1-year survival rate was 29%. Toxicity included mild, reversible visual changes (haziness, altered night vision), grade 1–3
nausea/vomiting, and grade 1–2 diarrhea. The mean day 7 plasma fenretinide level was 2.90 ± 1.66 μg/ml (7.40 ± 4.25 μM; n = 14). The mean pre-treatment and day 7 plasma retinol levels were 0.47 ± 0.16 μg/ml and 0.05 ± 0.07 μg/ml (n = 8), respectively. The mean day 7 salivary fenretinide level was 0.08 ± 0.18 μg/ml, with no correlation between salivary
and plasma drug levels. Conclusions Fenretinide is well tolerated in patients with SCLC and stabilization of disease was noted in 24% of patients with this aggressive
disease. However, after the first stage of enrollment, the response rate did not meet criteria to proceed with full trial
accrual. Plasma concentrations of fenretinide that induce cytotoxicity in vitro in SCLC cell lines are clinically achievable, but there were no objective responses. Non-invasive drug monitoring using saliva
underestimates systemic exposure. 相似文献
24.
Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes 总被引:3,自引:0,他引:3
Joshi-Barve S Barve SS Amancherla K Gobejishvili L Hill D Cave M Hote P McClain CJ 《Hepatology (Baltimore, Md.)》2007,46(3):823-830
Obesity and the metabolic syndrome are closely correlated with hepatic steatosis. Simple hepatic steatosis in nonalcoholic fatty liver disease can progress to nonalcoholic steatohepatitis (NASH), which can be a precursor to more serious liver diseases, such as cirrhosis and hepatocellular carcinoma. The pathogenic mechanisms underlying progression of steatosis to NASH remain unclear; however, inflammation, proinflammatory cytokines, and oxidative stress have been postulated to play key roles. We previously reported that patients with NASH have elevated serum levels of proinflammatory cytokines, such as interleukin-8 (IL-8), which are likely to contribute to hepatic injury. This study specifically examines the effect of hepatic steatosis on IL-8 production. We induced lipid accumulation in hepatocytes (HepG2, rat primary hepatocytes, and human primary hepatocytes) by exposing them to pathophysiologically relevant concentrations of palmitic acid to simulate the excessive influx of fatty acids into hepatocytes. Significant fat accumulation was documented morphologically by Oil Red O staining in cells exposed to palmitic acid, and it was accompanied by an increase in intracellular triglyceride levels. Importantly, palmitic acid was found to induce significantly elevated levels of biologically active neutrophil chemoattractant, IL-8, from steatotic hepatocytes. Incubation of the cells with palmitate led to increased IL-8 gene expression and secretion (both mRNA and protein) through mechanisms involving activation of nuclear factor kappaB (NF-kappaB) and c-Jun N-terminal kinase/activator protein-1. CONCLUSION: These data demonstrate for the first time that lipid accumulation in hepatocytes can stimulate IL-8 production, thereby potentially contributing to hepatic inflammation and consequent liver injury. 相似文献
25.
26.
27.
28.
Zimmerman CW Sheth SS 《Best practice & research. Clinical obstetrics & gynaecology》2011,25(2):167-174
Pelvic-organ-prolapse repair presents unique challenges to the pelvic surgeon. Historically, the unacceptable failure rates with traditional procedures have instigated the many conceptual and technique changes. Critical analysis of the biomechanics of normal and altered anatomy has shifted the primary focus of surgeries from the midline of the distal vagina to the interspinous diameter. In addition, just as surgeons in other fields have begun to incorporate bolsters into various types of repairs, the field of prolapse repair has seen a proliferation of materials that are available to help strengthen repairs. Much effort, time and significant resources have been invested in improving these repairs, but much remains to be learned. The rapid pace of change has prevented the development of the type of evidence-based data that are needed to analyse accurately the specific risks and benefits of the various available approaches. Conceptual changes in the aetiology of pelvic organ prolapse, pelvic biodynamics and the specific nature of connective tissue damage have helped to fuel the rapid pace of change. 相似文献
29.